The U.S. Meals and Drug Administration has authorized the humanized monoclonal antibody Zynyz (retifanlimab-dlwr) as the primary first-line remedy for…
Read More
The U.S. Meals and Drug Administration has authorized the humanized monoclonal antibody Zynyz (retifanlimab-dlwr) as the primary first-line remedy for…
Read More